Your browser doesn't support javascript.
loading
Cysteine-SILAC Mass Spectrometry Enabling the Identification and Quantitation of Scrambled Interchain Disulfide Bonds: Preservation of Native Heavy-Light Chain Pairing in Bispecific IgGs Generated by Controlled Fab-arm Exchange.
van den Bremer, Ewald T J; Labrijn, Aran F; van den Boogaard, Ramon; Priem, Patrick; Scheffler, Kai; Melis, Joost P M; Schuurman, Janine; Parren, Paul W H I; de Jong, Rob N.
Affiliation
  • van den Bremer ETJ; Genmab , Yalelaan 60, 3584CM, Utrecht, The Netherlands.
  • Labrijn AF; Genmab , Yalelaan 60, 3584CM, Utrecht, The Netherlands.
  • van den Boogaard R; Genmab , Yalelaan 60, 3584CM, Utrecht, The Netherlands.
  • Priem P; Genmab , Yalelaan 60, 3584CM, Utrecht, The Netherlands.
  • Scheffler K; Thermo Fisher Scientific GmbH , Im Steingrund 4-6, 63303, Dreieich, Germany.
  • Melis JPM; Genmab , Yalelaan 60, 3584CM, Utrecht, The Netherlands.
  • Schuurman J; Genmab , Yalelaan 60, 3584CM, Utrecht, The Netherlands.
  • Parren PWHI; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center , Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
  • de Jong RN; Genmab , Yalelaan 60, 3584CM, Utrecht, The Netherlands.
Anal Chem ; 89(20): 10873-10882, 2017 10 17.
Article in En | MEDLINE | ID: mdl-28922593
Bispecific antibodies (bsAbs) are one of the most versatile and promising pharmaceutical innovations for countering heterogeneous and refractory disease by virtue of their ability to bind two distinct antigens. One critical quality attribute of bsAb formation requiring investigation is the potential randomization of cognate heavy (H) chain/light (L) chain pairing, which could occur to a varying extent dependent on bsAb format and the production platform. To assess the content of such HL-chain swapped reaction products with high sensitivity, we developed cysteine-stable isotope labeling using amino acids in cell culture (SILAC), a method that facilitates the detailed characterization of disulfide-bridged peptides by mass spectrometry. For this analysis, an antibody was metabolically labeled with 13C3,15N-cysteine and incorporated into a comprehensive panel of distinct bispecific molecules by controlled Fab-arm exchange (DuoBody technology). This technology is a postproduction method for the generation of bispecific therapeutic IgGs of which several have progressed into the clinic. Herein, two parental antibodies, each containing a single heavy chain domain mutation, are mixed and subjected to controlled reducing conditions during which they exchange heavy-light (HL) chain pairs to form bsAbs. Subsequently, reductant is removed and all disulfide bridges are reoxidized to reform covalent inter- and intrachain bonds. We conducted a multilevel (Top-Middle-Bottom-Up) approach focusing on the characterization of both "left-arm" and "right-arm" HL interchain disulfide peptides and observed that native HL pairing was preserved in the whole panel of bsAbs produced by controlled Fab-arm exchange.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Antibodies, Bispecific / Cysteine / Disulfides / Tandem Mass Spectrometry Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Anal Chem Year: 2017 Type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Antibodies, Bispecific / Cysteine / Disulfides / Tandem Mass Spectrometry Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Anal Chem Year: 2017 Type: Article Affiliation country: Netherlands